Maximal tumor debulking with systemic therapy does not affect QoL in mCRC
Colorectal cancer, medical illustration 3D illustration: © Anatomy Insider – Stock.adobe.com Results from ORCHESTRA’s prespecified exploratory analysis show that even the addition of maximal tumor debulking to standard systemic therapy is associated with lower risk of cancer in patients with metastatic colorectal cancer (mCRC) compared to systemic therapy alone. trial (NCT01792934) that had no significant […]
Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago
Targeted Oncology Metastatic Colorectal Cancer: Treatment Strategies and Hope for Patients An expert perspective on comprehensive treatment strategies for metastatic colorectal cancer, including systemic therapy, precision medicine….50 minutes ago